ProQR (PRQR) Secures Fast Track Designation from FDA for QR-421a for Usher Syndrome Type 2

January 2, 2019 7:03 AM

ProQR Therapeutics N.V. (NASDAQ: PRQR) today announced that it received Fast Track designation from the Food and Drug Administration (FDA) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found